Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
06/03/2003 | US6573099 Genetic constructs for delaying or repressing the expression of a target gene |
06/03/2003 | US6573098 Nucleic acid libraries |
06/03/2003 | US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer |
06/03/2003 | US6573086 Transformed/transfected Chrysosporium lucknowense expressing/ secreting heterologous polypeptides; signal sequences; regula -tory sequences; mutants; Trichoderma reesei; use in making large amounts of protein/polypeptide in a low cost manner |
06/03/2003 | US6573084 Culture of Streptomyces anulatus 4811 (FERM BP-5808); deacylation of the lipid acyl moiety of FR-901379, Echinocandin B, and Aculeacin A |
06/03/2003 | US6573077 Active site of human gamma glutamyl hydrolase |
06/03/2003 | US6573076 Genes and encoded enzymes involved in cellulose biosynthesis by a bacterium; Acetobacter xylinum subsp. sucrofermentans; cellulase; cellulose synthase; use in transformation/genetic engineering of cellulose production in microorganisms |
06/03/2003 | US6573075 Fumonisin detoxification compositions and methods |
06/03/2003 | US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders |
06/03/2003 | US6573065 Thermostable proteolytic enzymes and uses thereof in peptide protein synthesis |
06/03/2003 | US6573062 Method for obtaining modulators of TNF receptor releasing enzyme |
06/03/2003 | US6573060 Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives |
06/03/2003 | US6573059 DNA construct for the preparation of a fusion protein; green fluorescent protein |
06/03/2003 | US6573056 Process for purifying factor VII and activated factor VII |
06/03/2003 | US6573050 Reducing expression of tyrosinase related proteins (TYRP2) in cancer cells by contacting the cells with an antisense oligonucleotide targeting mRNA of the protein |
06/03/2003 | US6572854 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
06/03/2003 | CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use |
06/03/2003 | CA2116224C Novel alpha-mannosidase inhibitors |
05/30/2003 | WO2003044529A1 Modulators of lymphocyte activation, mkk3b compositions and methods of use |
05/30/2003 | WO2003044218A1 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222 |
05/30/2003 | WO2003044214A2 Methods and compositions in checkpoint signaling |
05/30/2003 | WO2003044205A1 Method for production of asymmetric carotenoids |
05/30/2003 | WO2003044201A1 Genetically modified plants with enhanced resistance to fungal diseases and a method of production thereof |
05/30/2003 | WO2003044200A1 Nucleotide sequence coding for an enzyme having acetolactase synthase activity, plant cell and plant containing same, and crop weeding method |
05/30/2003 | WO2003044199A1 Recombinant bacillus phytases and uses thereof |
05/30/2003 | WO2003044186A2 Novel gene cluster of pederin biosynthesis genes |
05/30/2003 | WO2003044185A2 Purified polypeptides involved in general metabolism |
05/30/2003 | WO2003044179A2 Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon |
05/30/2003 | WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
05/30/2003 | WO2003044169A2 Compositions and methods for reversibly inducing continual growth in normal cells |
05/30/2003 | WO2003044168A2 Facilitation of rna interference |
05/30/2003 | WO2003044050A1 Method for producing a recombinant protein using pollen |
05/30/2003 | WO2003044043A1 Method of protein purification |
05/30/2003 | WO2003043978A2 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking |
05/30/2003 | WO2003025164A3 A gene encoding cyclododecanone monooxygenase |
05/30/2003 | WO2003014721A3 Chimeric protein and its use in electron transfer methods |
05/30/2003 | WO2003014341A3 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
05/30/2003 | WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
05/30/2003 | WO2003002735A3 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
05/30/2003 | WO2002097059A3 Chromosome-based platforms |
05/30/2003 | WO2002094123A3 Method of preparing a dought with an enzime |
05/30/2003 | WO2002089829A3 Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer |
05/30/2003 | WO2002088176A3 Genes and proteins for the biosynthesis of polyketides |
05/30/2003 | WO2002072806A3 Variant glutaryl amidase (cephalosporin acylase) and uses thereof |
05/30/2003 | WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
05/30/2003 | WO2002058624A3 In situ generation allicin for the treatment of cancer and infectious diseases |
05/30/2003 | WO2002051992A3 21163, a novel human prolyl oligopeptidase and uses therefor |
05/30/2003 | WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof |
05/30/2003 | WO2002048372A3 Target enzymes |
05/30/2003 | WO2002047717A9 Targeted enzyme prodrug therapy |
05/30/2003 | WO2002008382A3 Controlled environment agriculture bioreactor for heterologous protein production |
05/30/2003 | WO2001087922A3 Derivatisation of proteins in aqueous solution |
05/30/2003 | WO2001075075A3 Human tyrosine phosphatase-like enzymes |
05/30/2003 | CA2468096A1 Method for production of asymmetric carotenoids |
05/30/2003 | CA2467048A1 Method of protein purification |
05/30/2003 | CA2463862A1 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking |
05/30/2003 | CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
05/29/2003 | US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
05/29/2003 | US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants |
05/29/2003 | US20030101487 Generation of genetically engineered tomatoes containing high concentrations of glutamic acid, asparagine, aspartic acid, serine, threonine, alanine and histidine |
05/29/2003 | US20030101486 Schizochytrium PKS genes |
05/29/2003 | US20030101485 Oligonucleotides for use in gene expression inhibition in plants |
05/29/2003 | US20030101484 Maize chitinases and their use in enhancing disease resistance in crop plants |
05/29/2003 | US20030101478 Compositions and methods for the modification of gene expression |
05/29/2003 | US20030101477 Generation of transgenic cells with amplified naringenin and kaempferol concentrations |
05/29/2003 | US20030101476 Recombinant phytases and uses thereof |
05/29/2003 | US20030101474 Regulatory sequences associated with the control of gene expression in plants |
05/29/2003 | US20030101470 Animal model for use in diagnosis, prevention and treatment of bone, splenic, blood, inflammatory and nervous system disorders |
05/29/2003 | US20030101005 Crystals and structures of perosamine synthase homologs |
05/29/2003 | US20030100749 Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes |
05/29/2003 | US20030100746 Methods and materials relating to fibulin-like polypeptides and polynucleotides |
05/29/2003 | US20030100744 Cytochrome P450 oxygenases |
05/29/2003 | US20030100743 Nucleic acids and proteins with thioredoxin reductase activity |
05/29/2003 | US20030100740 Protein for use in the treatment of blood disorders |
05/29/2003 | US20030100726 Secreted transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100723 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100720 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100715 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100713 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100711 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100710 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100708 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100528 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
05/29/2003 | US20030100506 Modified Vitamin K-dependent polypeptides |
05/29/2003 | US20030100497 For stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals |
05/29/2003 | US20030100489 For determining if a subject is at risk for a disorder characterized by unwanted cell proliferation |
05/29/2003 | US20030100480 Methods and compositions for modulating sebaceous glands |
05/29/2003 | US20030100479 Gene polymorphisms and response to treatment |
05/29/2003 | US20030100467 Binding phenol oxidizing enzyme-peptide complexes |
05/29/2003 | US20030100110 Vector for use as a propagation tool in genetic engineering |
05/29/2003 | US20030100095 New human cathepsin |
05/29/2003 | US20030100094 Method for engineering strand-specific, sequence-specific, DNA-nicking enzymes |
05/29/2003 | US20030100093 Human telomerase catalytic subunit: diagnostic and therapeutic methods |
05/29/2003 | US20030100092 For reducing the phospholipid content of an aqueous carbohydrate solution or slurry; used in dough |
05/29/2003 | US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
05/29/2003 | US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay |
05/29/2003 | US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders |
05/29/2003 | US20030100080 Nucleotide sequences coding polypeptide for use in the prepration of amino acid for use in human medicines, nutrients and food processing |
05/29/2003 | US20030100079 Novel nucleotide sequences coding for the genes sdhA, sdhB and sdhC |